Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Turnstone Biologics Corp. - Common Stock (NQ: TSBX )

0.4705 -0.0275 (-5.52%)
Streaming Delayed Price Updated: 3:38 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Turnstone Biologics Corp. - Common Stock

< Previous 1 2 Next >
Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber
Internationally recognized thought leader with extensive experience in innovative immunotherapies for solid tumors will help guide Turnstone’s continued advancement of its Selected TIL therapies 
From Turnstone Biologics Corp.
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to dive into the biggest pre-market stock movers with all the most recent news moving shares on Tuesday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers ParaZero Technologies Ltd. (NASDAQ: PRZO) shares jumped 106% to $2.3901 after the company announced an Australian regulator approved first commercial drone flights in populated areas and near... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
From Turnstone Biologics Corp.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
  During the session on Thursday, 461 stocks hit new 52-week lows. 
Via Benzinga
Top 4 Health Care Stocks That Could Lead To Your Biggest Gains In Q3
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update
From Turnstone Biologics Corp.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
Via Benzinga
Alcoholic Beverage Marketing Company LQR Debuts On Nasdaq
LQR House, which provides digital marketing and branding services to the alcohol industry, went public on Thursday, raising $5 million million in its IPO. Meanwhile NeurAxis, raised $7 million in its... 
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
Beauty Brand Owner Oddity Soars In Debut
Via Talk Markets
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.